Detection of Soluble ED-A+ Fibronectin and Evaluation as Novel Serum Biomarker for Cardiac Tissue Remodeling
Background and Aims. Fibronectin containing the extra domain A (ED-A+ Fn) was proven to serve as a valuable biomarker for cardiac remodeling. The study was aimed at establishing an ELISA to determine ED-A+ Fn in serum of heart failure patients. Methods. ED-A+ Fn was quantified in serum samples from...
Main Authors: | Barbara Ziffels, Johanna Ospel, Katja Grün, Dario Neri, Alexander Pfeil, Michael Fritzenwanger, Hans R. Figulla, Christian Jung, Alexander Berndt, Marcus Franz |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2016/3695454 |
Similar Items
-
Serum Liberation of Fetal Fibronectin Variants in Patients with Pulmonary Hypertension: ED-A<sup>+</sup> Fn as Promising Novel Biomarker of Pulmonary Vascular and Right Ventricular Myocardial Remodeling
by: Laura Bäz, et al.
Published: (2021-06-01) -
Increased Serum Levels of Fetal Tenascin-C Variants in Patients with Pulmonary Hypertension: Novel Biomarkers Reflecting Vascular Remodeling and Right Ventricular Dysfunction?
by: Ilonka Rohm, et al.
Published: (2017-11-01) -
Serum Biomarkers of Cardiovascular Remodelling Reflect Extra-Valvular Cardiac Damage in Patients with Severe Aortic Stenosis
by: Laura Bäz, et al.
Published: (2020-06-01) -
Profile of Matrix-Remodeling Proteinases in Osteoarthritis: Impact of Fibronectin
by: Selene Pérez-García, et al.
Published: (2019-12-01) -
Elevated Plasma Levels of Interleukin-12p40 and Interleukin-16 in Overweight Adolescents
by: Michael Lichtenauer, et al.
Published: (2015-01-01)